Herpes Zoster Nosode – Shingles Nosode

The attenuations of this nosode are prepared from killed Herpes Zoster viruses (adjusted to 10⁶ plaque-forming units per milliliter).

Indications for the use of this viral nosode are provided not only by herpes zoster itself, and the unpleasant and painful herpetic eruptions, labial, genital or elsewhere, which often occur during menstruation, but also in pre-cancerous states of the uterus, or in outright cancer of the womb or parts of it, since relationships have come to light between the Herpes Zoster Nosode and the genesis of uterine cancer.

See also under “Herpes Simplex Nosode”.